185 related articles for article (PubMed ID: 33184843)
21. Study of melanocyte density and epidermal thickness in vulvar lichen sclerosus lesions.
Fu Y; Bao Y; Li Z; Gao X; Chang J
Int J Dermatol; 2021 Aug; 60(8):991-995. PubMed ID: 33870483
[TBL] [Abstract][Full Text] [Related]
22. The analysis of coexistence of celiac disease and vulvar lichen sclerosus in girls.
Nizinski K; Orszulak D; Janik M; Skowronek K; Stojko R; Drosdzol-Cop A
Ginekol Pol; 2022; 93(10):793-798. PubMed ID: 36748173
[TBL] [Abstract][Full Text] [Related]
23. A large sample-based case-control study of related risk factors of two types of lichenoid vulvar disease (LVD).
Wei D; Luo C; Chen Y; Li J; Niu X
Eur J Obstet Gynecol Reprod Biol; 2024 Feb; 293():15-20. PubMed ID: 38100936
[TBL] [Abstract][Full Text] [Related]
24. High-frequency ultrasound features in vulvar lichen sclerosus and correlation with histopathology.
Zhou MY; Wang YK; Zhu QL; Liu J
Skin Res Technol; 2022 Nov; 28(6):780-785. PubMed ID: 35969183
[TBL] [Abstract][Full Text] [Related]
25. Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series.
Smith SD; Fischer G
Pediatr Dermatol; 2009; 26(6):725-9. PubMed ID: 20199450
[TBL] [Abstract][Full Text] [Related]
26. Clearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera?
Borghi A; Virgili A; Minghetti S; Toni G; Corazza M
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):96-101. PubMed ID: 28796915
[TBL] [Abstract][Full Text] [Related]
27. The long-term clinical consequences of juvenile vulvar lichen sclerosus: A systematic review.
Morrel B; van Eersel R; Burger CW; Bramer WM; Ten Kate-Booij MJ; van der Avoort IAM; Pasmans SGMA
J Am Acad Dermatol; 2020 Feb; 82(2):469-477. PubMed ID: 31437545
[TBL] [Abstract][Full Text] [Related]
28. Vulvar lichen sclerosus in women of reproductive age.
Kolitz E; Gammon L; Mauskar M
Proc (Bayl Univ Med Cent); 2021 Feb; 34(3):349-351. PubMed ID: 33953458
[TBL] [Abstract][Full Text] [Related]
29. Pregnancy, parturition and postpartum considerations among patients with vulvar lichen sclerosus: A retrospective cross-sectional online survey.
Shaffer AB; Cigna ST; Pope R; Krapf JM
BJOG; 2024 Feb; 131(3):327-333. PubMed ID: 37424180
[TBL] [Abstract][Full Text] [Related]
30. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics.
Jones RW; Scurry J; Neill S; MacLean AB
Am J Obstet Gynecol; 2008 May; 198(5):496.e1-3. PubMed ID: 17905173
[TBL] [Abstract][Full Text] [Related]
31. Quality of Life in Vulvar Lichen Sclerosus Patients Treated With Long-Term Topical Corticosteroids.
Wijaya M; Lee G; Fischer G; Lee A
J Low Genit Tract Dis; 2021 Apr; 25(2):158-165. PubMed ID: 33746196
[TBL] [Abstract][Full Text] [Related]
32. The Female Genital Self-image Scale in Adult Women With Vulvar Lichen Sclerosus.
Hodges KR; Wiener CE; Vyas AS; Turrentine MA
J Low Genit Tract Dis; 2019 Jul; 23(3):210-213. PubMed ID: 31135654
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
Funaro D; Lovett A; Leroux N; Powell J
J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylation-Induced Inactivation of the IRF6 Gene as a Possible Early Event in Progression of Vulvar Squamous Cell Carcinoma Associated With Lichen Sclerosus.
Rotondo JC; Borghi A; Selvatici R; Magri E; Bianchini E; Montinari E; Corazza M; Virgili A; Tognon M; Martini F
JAMA Dermatol; 2016 Aug; 152(8):928-33. PubMed ID: 27223861
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the Vulvar Skin Microbiota in Asymptomatic Women and Patients With Vulvar Lichen Sclerosus Based on 16S rRNA Sequencing.
Liu X; Zhuo Y; Zhou Y; Hu J; Wen H; Xiao C
Front Cell Dev Biol; 2022; 10():842031. PubMed ID: 35445011
[TBL] [Abstract][Full Text] [Related]
36. What differentiates symptomatic from asymptomatic women with lichen sclerosus?
Vieira-Baptista P; Lima-Silva J; Cavaco-Gomes J; Beires J; Martinez-de-Oliveira J
Gynecol Obstet Invest; 2015; 79(4):263-8. PubMed ID: 25342279
[TBL] [Abstract][Full Text] [Related]
37. Novel Therapeutic Approaches and Targets for Treatment of Vulvar Lichen Sclerosus.
Borghi A; Corazza M
Curr Pharm Biotechnol; 2021; 22(1):99-114. PubMed ID: 32416670
[TBL] [Abstract][Full Text] [Related]
38. A population-based case-control study of aetiological factors associated with vulval lichen sclerosus.
Higgins CA; Cruickshank ME
J Obstet Gynaecol; 2012 Apr; 32(3):271-5. PubMed ID: 22369403
[TBL] [Abstract][Full Text] [Related]
39. Fractional CO2 laser and vulvar lichen sclerosus: an alternative resource during maintenance therapy? A prospective study.
Ferrara F; Filippi F; Messori S; Iommi M; Patrizi A; D'Antuono A; Gaspari V; Chessa MA; Baraldi C; Bardazzi F
Ital J Dermatol Venerol; 2022 Jun; 157(3):247-253. PubMed ID: 34282866
[TBL] [Abstract][Full Text] [Related]
40. Comorbidity of Urogynecological and Gastrointestinal Disorders in Female Patients With Lichen Sclerosus.
Söderlund JM; Hieta NK; Kurki SH; Orte KJ; Polo-Kantola P; Hietanen SH; Haataja MAM
J Low Genit Tract Dis; 2023 Apr; 27(2):156-160. PubMed ID: 36821789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
